![Tom Hochuli](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
Tom Hochuli is currently the Chief Executive Officer & Director at Vibalogics GmbH and the President at Be The Match Biotherapies.
Posizioni attive di Tom Hochuli
Società | Posizione | Inizio |
---|---|---|
Vibalogics GmbH
![]() Vibalogics GmbH BiotechnologyHealth Technology Vibalogics GmbH develops therapeutic and prophylactic vaccines and biological products. The company is headquartered in Cuxhaven, Germany. | Amministratore Delegato | 01/01/2020 |
Be The Match Biotherapies
![]() Be The Match Biotherapies BiotechnologyHealth Technology Part of The Marrow Foundation, Be The Match Biotherapies is a company that partners with cell and gene therapy companies to provide customizable services to support the entire end-to-end cell therapy supply chain. The company is based in Minneapolis, MN. The company has extensive experience providing cellular source material consented for research, clinical and commercial use. The company was founded in 2016. The CEO is Amy L. Ronneberg. | Presidente | 30/01/2024 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Vibalogics GmbH
![]() Vibalogics GmbH BiotechnologyHealth Technology Vibalogics GmbH develops therapeutic and prophylactic vaccines and biological products. The company is headquartered in Cuxhaven, Germany. | Health Technology |
Be The Match Biotherapies
![]() Be The Match Biotherapies BiotechnologyHealth Technology Part of The Marrow Foundation, Be The Match Biotherapies is a company that partners with cell and gene therapy companies to provide customizable services to support the entire end-to-end cell therapy supply chain. The company is based in Minneapolis, MN. The company has extensive experience providing cellular source material consented for research, clinical and commercial use. The company was founded in 2016. The CEO is Amy L. Ronneberg. | Health Technology |
- Borsa valori
- Insiders
- Tom Hochuli